THE TREATMENT OF THE PARKINSONIAN SYNDROME WITH BULGARIAN BELLADONNA ROOT AND AMPHETAMINE (BENZEDRINE) SULFATE
Abstract
1. A series of 25 patients with Parkinsonian syndrome, including 15 of the post-encephalitic type, and 10 of the arteriosclerotic or idiopathic type have been treated with the combination of Bulgarian belladonna root (rabellon) and amphetamine (benzedrine) sulfate. Of the post-encephalitic cases, 11 showed some improvemnet. Of the other types, five were beneficially influenced.
2. Our experience indicated that this therapy is superior to other forms of treatment.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
